Nathaniel W. Mabe

605 total citations
14 papers, 254 citations indexed

About

Nathaniel W. Mabe is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Nathaniel W. Mabe has authored 14 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Neurology and 4 papers in Oncology. Recurrent topics in Nathaniel W. Mabe's work include Neuroblastoma Research and Treatments (4 papers), Protein Degradation and Inhibitors (4 papers) and Epigenetics and DNA Methylation (3 papers). Nathaniel W. Mabe is often cited by papers focused on Neuroblastoma Research and Treatments (4 papers), Protein Degradation and Inhibitors (4 papers) and Epigenetics and DNA Methylation (3 papers). Nathaniel W. Mabe collaborates with scholars based in United States. Nathaniel W. Mabe's co-authors include James V. Alvarez, Ryan Lupo, Kimberly Stegmaier, Clare F. Malone, Douglas B. Fox, Jennifer A. Perry, Jen‐Tsan Chi, Chao‐Chieh Lin, Amy E. Decker and Boyd R. Rorabaugh and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Nathaniel W. Mabe

13 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathaniel W. Mabe United States 10 190 62 56 38 28 14 254
Christina Wu United States 8 305 1.6× 81 1.3× 57 1.0× 52 1.4× 29 1.0× 25 395
Weihai Ning China 10 145 0.8× 48 0.8× 94 1.7× 43 1.1× 16 0.6× 33 251
Mengzhu Yang China 10 173 0.9× 99 1.6× 103 1.8× 36 0.9× 38 1.4× 18 276
Azusa Yamato Japan 8 207 1.1× 73 1.2× 64 1.1× 55 1.4× 28 1.0× 12 313
Jou‐Ho Shih Taiwan 8 222 1.2× 77 1.2× 112 2.0× 31 0.8× 29 1.0× 10 292
Yunfei Liao China 10 187 1.0× 31 0.5× 58 1.0× 31 0.8× 19 0.7× 20 246
Quanbin Zhang China 9 165 0.9× 33 0.5× 54 1.0× 18 0.5× 30 1.1× 16 268
Mariaelena Pistoni Italy 12 240 1.3× 29 0.5× 62 1.1× 13 0.3× 20 0.7× 21 321
Élodie Montaudon France 8 115 0.6× 133 2.1× 53 0.9× 82 2.2× 15 0.5× 23 251

Countries citing papers authored by Nathaniel W. Mabe

Since Specialization
Citations

This map shows the geographic impact of Nathaniel W. Mabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel W. Mabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel W. Mabe more than expected).

Fields of papers citing papers by Nathaniel W. Mabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathaniel W. Mabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel W. Mabe. The network helps show where Nathaniel W. Mabe may publish in the future.

Co-authorship network of co-authors of Nathaniel W. Mabe

This figure shows the co-authorship network connecting the top 25 collaborators of Nathaniel W. Mabe. A scholar is included among the top collaborators of Nathaniel W. Mabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathaniel W. Mabe. Nathaniel W. Mabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kendsersky, Nathan M., Nathaniel W. Mabe, Alvin Farrel, et al.. (2025). Lineage dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and -independent immunotherapeutic targets. Neuro-Oncology. 27(5). 1372–1384. 1 indexed citations
2.
Malone, Clare F., Nathaniel W. Mabe, Gabriela Alexe, et al.. (2024). The KAT module of the SAGA complex maintains the oncogenic gene expression program in MYCN- amplified neuroblastoma. Science Advances. 10(22). eadm9449–eadm9449. 4 indexed citations
3.
Mabe, Nathaniel W., Jennifer A. Perry, Clare F. Malone, & Kimberly Stegmaier. (2024). Pharmacological targeting of the cancer epigenome. Nature Cancer. 5(6). 844–865. 27 indexed citations
4.
Lu, Diana, Jana M. Ellegast, Kenneth N. Ross, et al.. (2023). The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma. Nature Cell Biology. 25(2). 285–297. 24 indexed citations
5.
Dalton, Guillermo Nicolás, Won‐Ju Kim, Nathaniel W. Mabe, et al.. (2023). 244 Targeting gangliosides in pediatric cancer. SHILAP Revista de lepidopterología. A283–A283. 2 indexed citations
6.
Kendsersky, Nathan M., et al.. (2022). Abstract 3889: Identification of ADRN-specific, MES-specific, and pan-subtype therapeutic targets in neuroblastoma. Cancer Research. 82(12_Supplement). 3889–3889.
7.
Lin, Chao‐Chieh, Nathaniel W. Mabe, Yi-Tzu Lin, et al.. (2020). RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence. Cell Death and Differentiation. 27(7). 2234–2247. 45 indexed citations
8.
Mabe, Nathaniel W., Rachel Newcomb, Ryan Lupo, et al.. (2020). G9a Promotes Breast Cancer Recurrence through Repression of a Pro-inflammatory Program. Cell Reports. 33(5). 108341–108341. 27 indexed citations
9.
Walens, Andrea, Jiaxing Lin, Jeffrey S. Damrauer, et al.. (2020). Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence. Nature Communications. 11(1). 5017–5017. 34 indexed citations
10.
11.
Damrauer, Jeffrey S., Ryan Lupo, Nathaniel W. Mabe, et al.. (2018). Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K–Akt Inhibition. Molecular Cancer Research. 16(4). 599–609. 10 indexed citations
12.
Mabe, Nathaniel W., Douglas B. Fox, Ryan Lupo, et al.. (2018). Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer. Journal of Clinical Investigation. 128(10). 4413–4428. 34 indexed citations
13.
Rorabaugh, Boyd R., Bandana Chakravarti, Nathaniel W. Mabe, et al.. (2016). Regulator of G Protein Signaling 6 Protects the Heart from Ischemic Injury. Journal of Pharmacology and Experimental Therapeutics. 360(3). 409–416. 17 indexed citations
14.
Thompson, Corbin G., Nathaniel W. Mabe, Kuljeet Kaur, et al.. (2011). Gαi2-mediated protection from ischaemic injury is modulated by endogenous RGS proteins in the mouse heart. Cardiovascular Research. 91(1). 45–52. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Wu Breakdown of academic impact, for papers by Weihai Ning Breakdown of academic impact, for papers by Mengzhu Yang Breakdown of academic impact, for papers by Azusa Yamato Breakdown of academic impact, for papers by Jou‐Ho Shih Breakdown of academic impact, for papers by Yunfei Liao Breakdown of academic impact, for papers by Quanbin Zhang Breakdown of academic impact, for papers by Mariaelena Pistoni Breakdown of academic impact, for papers by Élodie Montaudon
Rankless by CCL
2026